Evidence map›Paper›PMID 41466384›Full record

ArticleJournal of medical case reports2025

Cranial neuropathy during severe acute respiratory syndrome coronavirus 2 infection: a case report.

Roya Yazdani, Farzaneh Barzkar, Zahra Mirzaasgari

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Roya YazdaniDepartment of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
Farzaneh BarzkarNational Brain Centre, Iran University of Medical Sciences, Tehran, Iran.
Zahra MirzaasgariDepartment of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran. mirzaasgari@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCranial neuropathy has been reported in association with coronavirus disease 2019. Multiple reports have highlighted the possibility of Miller Fisher syndrome as a delayed immune-mediated response to severe acute respiratory syndrome coronavirus 2 infection. However, cranial neuropathy during the infectious phase of coronavirus disease 2019 with positive cerebrospinal fluid polymerase chain reaction has not been reported to date. CASE PRESENTATION: We report a 53-year-old Iranian woman who presented with right ptosis, diplopia, and headache without any respiratory symptoms of coronavirus disease 2019. Further evaluations revealed severe acute respiratory syndrome coronavirus(SARS CoV) 2 in the patient's nasopharyngeal sample and cerebrospinal fluid. The patient's neurological symptoms improved after treatment with remdesivir and corticosteroids.

conclusionWe suggest that cranial nerve-related symptoms can occur in the context of acute severe acute respiratory syndrome coronavirus 2 infection via direct viral invasion and secondary immune-mediated injury following primary infection. Clinicians should consider coronavirus disease 2019 in patients with symptoms related to cranial nerve involvement, even without systemic or respiratory symptoms of this viral infection.

Indexed as

COVID-19Cranial Nerve DiseasesAdenosine MonophosphateAdrenal Cortex HormonesAlanineAntiviral AgentsBlepharoptosisCOVID-19 Drug TreatmentDiplopiaFemaleHeadacheHumansIranMiddle AgedSARS-CoV-2Adenosine MonophosphateAdrenal Cortex HormonesAlanineAntiviral AgentsremdesivirCase reportCOVID-19Cranial neuropathyDiplopiaNeurologyPtosis

Identifiers

PMID41466384
PMCPMC12750738

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.